Stocks · News reference

Biomerica shares are trading higher after the company announced that it has entered into definitive agreements with institutional and individual investors for a private placement of 1,393,705 unregistered shares of the company’s common stock at a price of $1.60 per share.

Aug 27, 2026, 3:56 PMBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaSep 1, 2026, 12:27 PMBenzinga Newsdesk
Biomerica Q4 EPS $(0.38) Up From $(0.69) YoY, Sales $875.000K Up From $749.000K YoY
Biomerica (NASDAQ:BMRA) reported quarterly losses of $(0.38) per share. This is a 44.93 percent increase over losses of $(0.69) per share from the same period last year. The company reported $875.000 thousand in sales
BMRA
BenzingaAug 28, 2026, 7:27 PMCaroline Ryan
Deal Dispatch: Carets Corp Explores Strategic Alternatives, nVent Electric Buys Maverick Power for $1.75 Billion, BioXcel Bankruptcy
Major M&A deals this week include: The Descartes Systems buys Tai, KKR nabs Ci FLAVORS, Skimmer Acquires Pool Builder Geek and Poologics.
AME BAH BMRA BTAI BTGO
BenzingaAug 27, 2026, 12:21 PMBenzinga Newsdesk
Biomerica Commences ~$2.23M Private Placement Of 1.394M Shares At $1.60 Per Share
Biomerica, Inc. (NASDAQ:BMRA) ("Biomerica" or the "Company"), a developer and manufacturer of diagnostic test systems, today announced that it has entered into definitive agreements with institutional
BMRA